Log in

Sensyne Health Share Forecast, Price & News

GBX 149.74
+0.74 (+0.50 %)
(As of 11/27/2020 11:15 AM ET)
Today's Range
Now: GBX 149.74
50-Day Range
MA: GBX 115.09
52-Week Range
Now: GBX 149.74
Volume10,930 shs
Average Volume262,329 shs
Market Capitalization£192.52 million
P/E RatioN/A
Dividend YieldN/A
Sensyne Health plc is a healthcare technology company that creates value from accelerating the discovery and development of new medicines and improving patient care through the analysis of real-world evidence from large databases of anonymised patient data in collaboration with NHS Trusts. These anonymised patient data are ethically sourced in that any analysis of anonymised patient data (and hence the Company's access to it) must be pre-approved for each programme on a case-by-case basis by the relevant NHS Trusts. This is to ensure that the purpose of the anonymisation and the proposed analysis are subject to appropriate ethical oversight and information governance, including conformance with NHS principles, UK data protection law and applicable regulatory guidance. Sensyne Health is an early signatory to the Department of Health and Social Care's ‘Initial Code of Conduct for data-driven health and care technology'.
Read More
Sensyne Health logo

Beat the Market (BTM) Rank

Analyst Opinion: 3.5Community Rank: 3.9Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.48 out of 5 stars

Industry, Sector and Symbol

Industry Health Information Services
Phone44 3300 581845



Sales & Book Value

Annual Sales£2.05 million
Cash FlowGBX 26.31 per share
Book ValueGBX 34.10 per share



Market Cap£192.52 million
Next Earnings DateN/A
GBX 149.74
+0.74 (+0.50 %)
(As of 11/27/2020 11:15 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive SENS News and Ratings via Email

Sign-up to receive the latest news and ratings for SENS and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles

Sensyne Health (LON:SENS) Frequently Asked Questions

How has Sensyne Health's stock price been impacted by COVID-19?

Sensyne Health's stock was trading at GBX 39 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, SENS shares have increased by 283.9% and is now trading at GBX 149.74.
View which stocks have been most impacted by COVID-19

Do Wall Street analysts recommend investors buy shares of Sensyne Health?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Sensyne Health in the last year. There are currently 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Sensyne Health

What stocks does MarketBeat like better than Sensyne Health?

Wall Street analysts have given Sensyne Health a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's winning trading ideas this year have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Sensyne Health wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

What price target have analysts set for SENS?

2 brokerages have issued twelve-month target prices for Sensyne Health's shares. Their forecasts range from GBX 195 to GBX 260. On average, they expect Sensyne Health's share price to reach GBX 227.50 in the next twelve months. This suggests a possible upside of 51.9% from the stock's current price.
View analysts' price targets for Sensyne Health

Who are some of Sensyne Health's key competitors?

What other stocks do shareholders of Sensyne Health own?

What is Sensyne Health's stock symbol?

Sensyne Health trades on the London Stock Exchange (LON) under the ticker symbol "SENS."

How do I buy shares of Sensyne Health?

Shares of SENS and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What is Sensyne Health's stock price today?

One share of SENS stock can currently be purchased for approximately GBX 149.74.

How big of a company is Sensyne Health?

Sensyne Health has a market capitalization of £192.52 million and generates £2.05 million in revenue each year. Sensyne Health employs 70 workers across the globe.

What is Sensyne Health's official website?

The official website for Sensyne Health is www.sensynehealth.com.

How can I contact Sensyne Health?

The company can be reached via phone at 44 3300 581845.

This page was last updated on 11/27/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.